Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
Recruiting · NCT06517953 · Registry updated 2024-07-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations | EGFR G719X; EGFR L861Q; EGFR S768I; Non-small Cell Lung Cancer Metastatic | Recruiting | Phase 2 | 2024-07-25 | NCT06517953 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sun Yat-sen University | 606 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |